Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
06660 AIM VACCINE
43.900+1.250+2.93%
Market Close
03/31 16:08 CCT
High
44.350
Open
41.000
Turnover
1.79M
Low
41.000
Pre Close
42.650
Volume
41.60K
Price Forecast
News
Comment
No Data
Company Overview
More
Le Meridien Vaccine Co., Ltd. is a Chinese company mainly engaged in vaccine R&D, manufacturing and sales. The company's products mainly include recombinant hepatitis B vaccine, human rabies vaccine, hepatitis A inactivated vaccine, mumps vaccine, nephrotic haemorrhagic fever inactivated vaccine, and MPSV4. The company's products are mainly used to treat hepatitis B, hepatitis A, mumps, hemorrhagic renal syndrome fever, rabies and meningococcal disease. The company's vaccines under development include the messenger ribonucleic acid (mRNA) COVID-19 (COVID-19) vaccine, inactivated COVID-19 vaccine, broad-spectrum COVID-19 vaccine, PCV13, PPSV23, and MCV4. The company mainly operates in the domestic market.
CEO： Yan Zhou
Market： Hong Kong motherboard
Listing Date： 10/06/2022
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet